tiprankstipranks
Genus PLC (GB:GNS)
LSE:GNS
UK Market
GNS
Genus plc
RESEARCH TOOLSreports
Want to see GB:GNS full AI Analyst Report?

Genus plc (GNS) Earnings Dates, Call Summary & Reports

66 Followers

Earnings Data

Report Date
Sep 10, 2026
TBA (Confirmed)
Period Ending
2026 (Q4)
Consensus EPS Forecast
―
Last Year’s EPS
0.27
Same Quarter Last Year
Analyst Consensus
Moderate Buy
Based on 3 Analysts Ratings

Earnings Call Summary

Q2 2025
Earnings Call Date:Feb 27, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call reflects a strong financial performance and strategic progress, particularly with PIC's growth and the VAP initiatives. However, ABS faces challenges in China and Brazil, and currency headwinds are impacting profitability. R&D spend has decreased, but the company remains committed to innovation. Overall, the positive aspects outweigh the negatives.
Company Guidance
In the call, Genus provided comprehensive guidance highlighting several key metrics. PIC, excluding China, achieved a notable 13% increase in operating profit for the first half of the fiscal year 2025. Despite challenges in China, Genus signed seven new royalty customers, establishing contracts with three of the top five producers in the largest porcine market globally. The company's Value Acceleration Program (VAP) is on track to deliver a GBP 21 million annual run rate benefit by the end of the fiscal year, with notable improvements in cash flow due to better inventory management. Adjusted operating profit saw a 19% growth, reaching GBP 45.2 million, and adjusted profit before tax increased by 21% to GBP 35.4 million. The interim dividend was maintained at 10.3p per share. Additionally, the company expects FDA approval for its PRRS Resistant Pig (PRP) in calendar year 2025, with ongoing regulatory engagements in other international markets showing promise. Despite foreign exchange headwinds, Genus reaffirmed its fiscal year 2025 profit before tax (PBT) guidance, anticipating significant growth in PBT in actual currency.
Strong Financial Performance in H1 FY25
Adjusted operating profit grew 19% to GBP 45.2 million, and adjusted profit before tax grew 21% to GBP 35.4 million. This was a record first-half performance.
PIC's Impressive Growth
PIC achieved a 13% increase in operating profit excluding China, and a 9% volume increase overall. Latin America showed standout growth with a 13% operating profit increase in constant currency.
Value Acceleration Program (VAP) Success
VAP initiatives have delivered significant benefits, with GBP 6.3 million achieved in the first half, and an expected GBP 21 million run rate benefit by the end of the fiscal year.
Progress in PRP Commercialization
Significant progress with the FDA for PRP approval, with site inspections conducted and expected approval in 2025, marking a major opportunity from Genus's R&D program.
Improved Cash Flow and Debt Management
Return to positive free cash flow with improved working capital and inventory management, and a net debt to EBITDA ratio of 2x, within the target range.

Genus plc (GB:GNS) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced
Daily Earnings Calendar >

GB:GNS Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Sep 10, 2026
2026 (Q4)
- / -
0.268―――
Feb 26, 2026
2026 (Q2)
0.46 / 0.60
0.39452.28% (+0.21)――
Sep 04, 2025
2025 (Q4)
- / 0.27
-0.085415.29% (+0.35)――
Feb 27, 2025
2025 (Q2)
- / 0.39
0.33119.03% (+0.06)――
Sep 05, 2024
2024 (Q4)
- / -0.09
0.304-127.96% (-0.39)――
Feb 22, 2024
2024 (Q2)
0.33 / 0.33
0.485-31.75% (-0.15)――
Sep 07, 2023
2023 (Q4)
- / 0.30
0.321-5.30% (-0.02)――
Feb 23, 2023
2023 (Q2)
- / 0.48
0.42115.20% (+0.06)――
Sep 08, 2022
2022 (Q4)
- / 0.32
0.24232.64% (+0.08)――
Feb 24, 2022
2022 (Q2)
- / 0.42
0.569-26.01% (-0.15)――
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

GB:GNS Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 26, 2026
3157.04 p2828.39 p-10.41%
Sep 04, 2025
2467.91 p2724.57 p+10.40%
Feb 27, 2025
1796.66 p1718.12 p-4.37%
Sep 05, 2024
1741.80 p1695.19 p-2.68%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Genus PLC (GB:GNS) report earnings?
Genus PLC (GB:GNS) is schdueled to report earning on Sep 10, 2026, TBA (Confirmed).
    What is Genus PLC (GB:GNS) earnings time?
    Genus PLC (GB:GNS) earnings time is at Sep 10, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Genus PLC stock?
          The P/E ratio of Genus plc is N/A.
            What is GB:GNS EPS forecast?
            Currently, no data Available